论文部分内容阅读
目的:观察中西医结合治疗毒性弥漫性甲状腺肿患者的临床效果。方法:选取100例毒性弥漫性甲状腺肿患者,随机分为实验组与对照组各50例,对照组单纯采用他巴唑治疗,实验组采用中医甲亢方联合他巴唑治疗,比较两组患者的临床效果。结果:与对照组比较,实验组患者毒性弥漫性甲状腺肿的治疗效果更佳;治疗6个月后,实验组甲亢诊断指数为(1.86±0.25)、FT3为(5.18±1.36)pmol/L、FT4为(8.14±2.21)pmol/L、TSH为(4.36±1.24)mIU/L、TSAb阳性率为10.0%,与对照组比较差异均具有统计学意义(P均<0.05)。结论:中西医结合治疗毒性弥漫性甲状腺肿疗效确切,安全性高,值得临床推广应用。
Objective: To observe the clinical effect of integrated traditional Chinese and western medicine in the treatment of patients with toxic diffuse goiter. Methods: 100 patients with diffuse toxic goiter were randomly divided into experimental group and control group of 50 cases, the control group was treated with only methimazole, the experimental group was treated with hyperthyroidism and methimazole treatment, the two groups of patients Clinical effect. Results: Compared with the control group, the experimental group was more effective in treating diffuse toxic goiter. After 6 months of treatment, the diagnostic index of hyperthyroidism in the experimental group was (1.86 ± 0.25) and FT3 was (5.18 ± 1.36) pmol / L, FT4 was (8.14 ± 2.21) pmol / L, TSH was (4.36 ± 1.24) mIU / L, TSAb positive rate was 10.0%, which was significantly different from the control group (all P <0.05). Conclusion: Integrative treatment of toxic diffuse goiter is effective, safe and worthy of clinical application.